Immunostaining of Ki-67 (cell proliferation marker) and E-Cadherin in a primary pancreatic cancer
Metastatic Pancreatic Cancer
Immunostaining of Ki-67 (cell proliferation marker) and E-Cadherin in a primary pancreatic cancer
Who We Are
We are a biomedical research team at the Barbara Ann Karmanos Cancer Institute and Wayne State University in Detroit, Michigan.
Between 2001-2021, our group was continuously supported by a grant from the National Cancer Institute.
What We Do
We study the biology of normal mammary gland development and breast cancer. In addition, we examine the genetic alterations that drive pancreatic carcinogenesis.
We develop novel genetically engineered models to study biological processes in vivo.
Contact Us
For more information about what we do, to join our team, or to financially support our research
Leave a message here
September 6, 2024:
"Study reveals promising approach for preventing or treating early-stage pancreatic cancer" WSU School of Medicine News highlighting our publication in Cell Reports.
Areas of Expertise
Mammary Gland Development
Breast Cancer
Pancreatic Cancer
Cytokine Signaling
Genome Engineering
In Vivo Cancer Progression Models
Tumor Cell Dormancy